{
    "Comprehensive Income": [],
    "Cost of Revenue": {
        "Total Cost of Revenue": [
            "cost of goods and services sold",
            "cost of goods sold"
        ]
    },
    "Gross Profit": [],
    "Income Before Taxes": [
        "income loss from continuing operations before income taxes extraordinary items noncontrolling interest"
    ],
    "Income Tax Expense": [
        "income tax expense benefit"
    ],
    "Net Income": [
        "net income loss",
        "profit loss"
    ],
    "Non-Operating Items": {
        "Interest Expense": [],
        "Interest Income": [],
        "Other Income (Expense)": [
            "business combination contingent consideration arrangements change in amount of contingent consideration liability1",
            "fair value adjustment of contingent consideration",
            "fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings",
            "gain loss on disposition of intangible assets",
            "gain loss on sale of property plant equipment",
            "gain on sale of rights",
            "gains losses on sales of assets",
            "income loss from equity method investments",
            "income loss from equity method investments net of tax",
            "unconsolidated joint business"
        ],
        "Total Non-Operating Items": [
            "other nonoperating income expense"
        ]
    },
    "Operating Expenses": {
        "Depreciation and Amortization": [
            "amortization and impairment of acquired intangible assets"
        ],
        "General and Administrative": [
            "selling general and administrative expense"
        ],
        "Other Operating Expenses": [
            "collaboration profit sharing",
            "collaborationprofitlosssharing",
            "collaborationprofitsharing",
            "litigation settlement expense",
            "other operating income expense net",
            "restructuring charges"
        ],
        "Research and Development": [
            "acquired in process research and development",
            "research and development expense excluding acquired in process cost",
            "research and development expense including acquired in process cost"
        ],
        "Sales and Marketing": [],
        "Total Operating Expenses": []
    },
    "Operating Income": [
        "operating income loss"
    ],
    "Other Comprehensive Income": [],
    "Per-Share Data": {
        "Basic EPS": [
            "earnings per share basic"
        ],
        "Diluted EPS": [
            "earnings per share diluted"
        ],
        "Weighted Average Shares Outstanding (Basic)": [],
        "Weighted Average Shares Outstanding (Diluted)": []
    },
    "Revenues": {
        "Total Revenues": [
            "other sales revenue net",
            "revenues",
            "revenuesfromanti c d20therapeuticprograms",
            "sales revenue goods net"
        ]
    },
    "__unmapped__": [
        "costs and expenses",
        "disposal group not discontinued operation loss gain on write down",
        "net income loss attributable to noncontrolling interest",
        "income loss from continuing operations before income taxes minority interest and income loss from equity method investments"
    ]
}
